Shabir Madhi to Anti-Retroviral Agents
                            
                            
                                This is a "connection" page, showing publications Shabir Madhi has written about Anti-Retroviral Agents.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            2,903
         
        
        
     
 
    
        
        - 
            The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J. 2021 Sep 01; 40(9S):S69-S78.
            
            
                Score: 0,540
             
- 
            Effect of HIV-exposure and timing of antiretroviral treatment initiation in children living with HIV on antibody persistence and memory responses to Haemophilus influenzae type b and pneumococcal polysaccharide-protein conjugate vaccines. Vaccine. 2020 03 10; 38(12):2651-2659.
            
            
                Score: 0,485
             
- 
            Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants. PLoS One. 2019; 14(4):e0215079.
            
            
                Score: 0,458
             
- 
            Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis. Lancet Infect Dis. 2015 Sep; 15(9):1066-1076.
            
            
                Score: 0,351
             
- 
            Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014 Feb 20; 28(4):531-41.
            
            
                Score: 0,320
             
- 
            Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J. 2013 Sep; 32(9):972-7.
            
            
                Score: 0,310
             
- 
            Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children. Clin Infect Dis. 2019 08 01; 69(4):687-696.
            
            
                Score: 0,117
             
- 
            Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041. Int J Tuberc Lung Dis. 2017 01 01; 21(1):38-45.
            
            
                Score: 0,098
             
- 
            Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
            
            
                Score: 0,086
             
- 
            HIV and pneumococcal disease. Curr Opin Infect Dis. 2007 Feb; 20(1):11-5.
            
            
                Score: 0,049
             
- 
            HIV and childhood tuberculosis: the way forward. Int J Tuberc Lung Dis. 2004 May; 8(5):675-82.
            
            
                Score: 0,041
             
- 
            Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009-2013. PLoS One. 2021; 16(8):e0255941.
            
            
                Score: 0,034
             
- 
            Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine. 2010 Feb 17; 28(7):1677-83.
            
            
                Score: 0,015